menu

Case Challenges in MS: Tailoring Therapy to Patient-Specific Characteristics

Be part of the knowledge.
Register

ReachMD is even better when
you join the community!
Registration is free and easy.

Register Now

Case Challenges in MS: Tailoring Therapy to Patient-Specific Characteristics

Case Challenges in MS: Tailoring Therapy to Patient-Specific Characteristics
RestartResume
Join Dr. Scott Newsome from Johns Hopkins Hospital in Baltimore, as he discusses optimizing therapeutic strategies for MS patients.

Available credits: 0.25

Time to complete: 15 minutes

Released:

Valid until:

Take Post-Test

If you’ve already completed the activity.

  • Overview

    The complexity and heterogeneity of multiple sclerosis (MS) pathogenesis renders its clinical course and response to therapy highly variable, particularly among special populations. This includes patients considering pregnancy or minority patients. This necessitates optimal strategies to personalize therapy and monitor disease activity and progression in special populations.

    This educational activity will review cutting-edge research on the unique considerations for prognosis, monitoring, and treatment response in special populations of MS patients. Focused attention will be given to translating research into optimized therapeutic strategies tailored to patient-specific characteristics with the goal of slowing disease progression. A compelling case study will be presented to illustrate clinically relevant challenges in disease management.

    Fee Information & Refund/Cancellation Policy:
    There is no fee for this educational activity.

    To download the slide handouts for this presentation, please click here.
  • Learning Objectives

    Upon completion of this activity, learners will be better able to:

    DESCRIBE the heterogeneity of the clinical and neuropathological characteristics of MS and evidence-based strategies to monitor disease progression and treatment failure

    EVALUATE best practices in the use of disease-modifying therapies in special populations with MS

  • Target Audience

    MS specialists, neurologists, internists, hospitalists, and nurses in MS center and hospital settings

  • Disclosure of Conflicts of Interest

    Global Education Group (Global) requires instructors, planners, managers and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Global for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

    The faculty reported the following financial relationships or relationships to products or devices they or their spouses/life partners have with commercial interests related to the content of this CME activity:

    Scott Newsome, DO, MSCS, FAAN
    Consultant/Independent Contractor: Biogen, Inc; Celgene Corporation; Genentech, Inc
    Grant/Research Support: Biogen, Inc; Genentech, Inc; Novartis Pharmaceuticals

    The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

    Global Education Group
    Ashley Marostica, RN, MSN; Andrea Funk; Liddy Knight: No relevant financial relationships with any commercial interests.

    Spire Learning
    Erika Langsfeld, BSMT, PhD, and Mairead Early: No relevant financial relationships with any commercial interests.

    Planner/Reviewer
    Lindsay Borvansky: No relevant financial relationships with any commercial interests.

    Off-Label Statement

    This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) and Spire Learning do not recommend the use of any agent outside of the labeled indications.

    The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

    Disclaimer:

    Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

  • Accreditation and Credit Designation Statements

    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and Spire Learning. Global is accredited by the ACCME to provide continuing medical education for physicians.

    Physician Credit Designation:

    Global Education Group designates this activity for a maximum of .25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Nursing Continuing Education

    Global Education Group is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s COA.

    This educational activity for .25 contact hours is provided by Global Education Group. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

    Global Contact Information

    For information about the accreditation of this program, please contact Global at 303-395-1782 or cme@globaleducationgroup.com.

    Instructions to Receive Credit

    There is no fee to participate in this activity. In order to receive credit, participants must review the materials on accreditation information, target audience, learning objectives, and disclosure information. Participants must complete the entire activity. Participants must also score 100% on the post-test and submit it, along with the credit application and evaluation form, to the Spire representative/address/fax number indicated. Statements of credit will be mailed within 4 to 6 weeks following the program.

    For information about the accreditation of this program, please contact Global at 303-395-1782 or inquire@globaleducationgroup.com

    Provider(s)/Educational Partner(s)

    This activity is jointly provided by Global Education Group and Spire Learning.

    Commercial Support:

    This activity is supported by an educational grant from Genentech, Inc.

     

  • System Requirements

    Our site requires a computer, tablet or mobile device and a connection to the Internet. For best results, a high-speed Internet connection is recommended (DSL/cable). We also recommend using the latest version of your favorite browser to ensure compliance with W3C standards, such as Internet Explorer, Microsoft Edge, Chrome, Firefox or Safari. Users accustomed to IE8, IE9 IE10 are advised to update their browsers for the best experience.

Facebook Comments

LIVE ON REACHMD RADIOBack to live radio
ReachMD Radio

Loading...

00:00
00:00

You must be in to display playlists.

Get a Dose of ReachMD in Your Inbox
and Practice Smarter Medicine

Stay current with the best in medical education.